Inactive Instrument

Biondvax Pharmaceuticals Ltd Stock

Equities

End-of-day quote TEL AVIV STOCK EXCHANGE Other stock markets
- ^ILa	-

Biondvax Pharmaceuticals : Announces Rights Offering Fully Subscribed at US$20 Million	19-07-16	PU
Biondvax Pharmaceuticals : First Participant Enrolled in Second Cohort of BiondVax’s Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial	19-07-08	PU
Biondvax Pharmaceuticals : European Investment Bank VP attends Signature Event at BiondVax Extending Financing Agreement with BiondVax to €24 million	19-06-26	PU
Biondvax Pharmaceuticals : Patent Covering Manufacturing Process of BiondVax’s M-001 Universal Flu Vaccine Allowed in USA and Japan	19-06-18	PU
Biondvax Pharmaceuticals : Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu Vaccine and Scale Up of Manufacturing Process	19-06-10	PU

Managers	Title	Age	Since
Amir Reichman CEO	Chief Executive Officer	49	21-03-01
Uri Ben-Or DFI	Director of Finance/CFO	52	06-12-31
Dalit Weinstein Fischer CTO	Chief Tech/Sci/R&D Officer	-	21-12-31

Members of the board	Title	Age	Since
Adi Raviv BRD	Director/Board Member	69	20-03-23
Samuel Moed BRD	Director/Board Member	62	20-03-23
Morris Laster BRD	Director/Board Member	60	17-11-26

Sector

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+0.17%	42.19B
MODERNA, INC.	+10.92%	42.24B
LONZA GROUP AG	+44.30%	40.15B
CELLTRION, INC.	-6.20%	28.31B
ICON PUBLIC LIMITED COMPANY	+5.23%	24.63B
ALNYLAM PHARMACEUTICALS, INC.	-24.79%	18.2B
MEDPACE HOLDINGS, INC.	+26.69%	12.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.13%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.57%	10.4B